News at CenExel

The Crucial Role of Phase I Clinical Trials in Advancing Medicine

    The Crucial Role of Phase I Clinical Trials in Advancing Medicine; by David Walling, PhD The journey from a promising scientific discovery to a safe and effective medication available to the public is a complex and rigorous process. At the heart of this...

Advancements in Vaccines: Bridging the Past and Future

    Advancements in Vaccines: Bridging the Past and Future - by Nelia Sanchez-Crespo, MD The history of vaccines is a testament to the incredible progress we've made in protecting humanity against infectious diseases. From the invention of the smallpox...

Understanding Alzheimer’s Disease: Recognizing Warning Signs

Understanding Alzheimer's Disease: Recognizing Warning Signs - by Sanjiv Sharma, MD, CPI Alzheimer's disease is a progressive neurological disorder that affects millions of people worldwide. It's the most common cause of dementia among older adults and presents a...

FDA Approves ABRYSVO for RSV

In the last week, the FDA approved the first maternal vaccine designed to safeguard infants from respiratory syncytial virus (RSV) during the critical period immediately from birth up to 6 months of age, when they are most vulnerable to infection. RSV, a highly...

Ethnic Bridging: The Who, the When, the Why

  In the dynamic realm of clinical drug development, a new star is rising: Ethnic Bridging clinical trials, also known as ethnobridging or Asian bridging clinical trials. Over the past several years, the industry has witnessed a surge in the adoption of these...

Placebo and Nocebo Response Mitigation

Empirical Strategies to Mitigate Placebo and Nocebo Effects CenExel sites are committed to enhancing understanding of the causes and implications of the placebo and nocebo effects within central nervous system and internal medicine clinical trials and developing...

Stuart Goldblatt Joins CenExel as CEO

Salt Lake City, July 17, 2023 /GlobeNewswire/ — The CenExel Board of Directors is delighted to announce that Stuart Goldblatt has joined CenExel as our new CEO effective July 17, 2023. Tom Wardle will transition to the role of Executive Chairman, CenExel Board of...

Michele Baptista Joins CenExel

Salt Lake City, May 18, 2023 /GlobeNewswire/ — CenExel announces the addition of Michele Baptista as the new Senior Director of Business Development. In this new capacity, Michele will be responsible for developing, selling, and supporting CenExel’s 18-site network...